Metabolon, Geisinger Team on Prediabetes Study | GenomeWeb

NEW YORK (GenomeWeb) – Metabolon announced that it is partnering with Geisinger Medical Center in Danville, Pa., on a pilot study to evaluate Metabolon's Quantose IR test in monitoring glycemic control in people with prediabetes.

The study will monitor prediabetic subjects over a 12-week period using the Quantose IR test and evaluate hemoglobin A1c and fasting plasma glucose results. Participants in the study will receive metformin treatment and also will be on a regiment of diet and exercise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.